Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Different countries have regulations to ensure the safety of hair care products, with some recalling hair straighteners due to high formaldehyde.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Minoxidil effectively treats female pattern hair loss.

Finasteride may help some women with hair loss, but better options exist.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Setipiprant did not significantly improve hair growth in men with hair loss.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Antioxidants might help prevent pressure ulcers, but more research is needed to find effective ones.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib successfully treated severe hair loss.